PK in Healthy Volunteers
2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Small Molecule
1100%
+ 1 programs with unclassified modality
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
PharmaEssentiaPEG-MetHuG-CSF
SanofiFexinidazole
Clinical Trials (2)
Total enrollment: 12 patients across 2 trials
A Phase I PK/PD Study of PEG-MetHuG-CSF (P2203) in Healthy Volunteers
Start: Aug 2024Est. completion: Feb 2025
Phase 1Completed
Fexinidazole (1200mg) Bioavailability Under Different Food Intake Conditions
Start: Feb 2011Est. completion: Apr 201112 patients
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
Small Molecule is the dominant modality (100% of programs)
2 companies competing in this space